Cantor Fitzgerald Reiterates Overweight Rating on NXP Semiconductors NV (NXPI)
Get Alerts NXPI Hot Sheet
Rating Summary:
26 Buy, 11 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 2 | Down: 3 | New: 5
Join SI Premium – FREE
Cantor Fitzgerald analyst Matthew Prisco reiterated an Overweight rating and $280.00 price target on NXP Semiconductors NV (NASDAQ: NXPI).
The analyst commented, "Amid Automotive fears, NXPI posted a modest topline beat/raise (as previewed), with mgmt. highlighting sequential growth across regions/end-markets and an outlook for continued sequential strength, driven by company-specific drivers and signs of cyclical recovery. From an end-market perspective, IIOT seemed to have tracked a touch worse-than-expected, offset by Mobile a touch better - but generally as expected. GMs came in as expected, Opex a touch higher in 4Q (assuming with Aviva/Kinara closures), and Interest/Other expense a touch higher (driving 3Q EPS to slightly miss consensus). Elsewhere, no change to channel inventory Q/Q and balance sheet days were up slightly in 3Q (potentially related to prebuilding for consolidation). Overall, this appears to be a solid report (with guidance better than many feared), with all eyes tomorrow focused around sustainability of the recovery (particularly amid the challenging Automotive headlines) and margin trajectory. We will update our model and thoughts tomorrow post-call (8am ET), but for now we reiterate our Overweight rating based on strong secular growth drivers and under-appreciated through-cycle resiliency, making NXPI one of the most undervalued names in Analog."
For an analyst ratings summary and ratings history on NXP Semiconductors NV click here. For more ratings news on NXP Semiconductors NV click here.
Shares of NXP Semiconductors NV closed at $221.56 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Upgrades QIAGEN NV (QIA:GR) (QGEN) to Overweight
- Sionna Therapeutics (SION) Reiterated at Market Outperform by Citizens: Readouts Upcoming
- AMN Healthcare (AMN) Reiterated at Market Outperform by Citizens
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Cantor Fitzgerald, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share